Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KATHLEEN MOORE

Allopathic & Osteopathic Physicians Obstetrics & Gynecology

NPI
1871680249
CMS profile
266763
Location
OKLAHOMA CITY, OK

General Payments · PY2018–2024

$687,618.49

  • Reported across 429 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$134,774.10

73 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Daiichi Sankyo Inc. $20,631.64 14
Genmab U.S., Inc. $19,361.77 4
Takeda Pharmaceuticals U.S.A., Inc. $16,798.41 6
ABBVIE INC. $15,664.80 4
GlaxoSmithKline, LLC. $14,566.74 5
Merck Sharp & Dohme Corporation $14,554.55 14
Corcept Therapeutics $7,898.65 4
BioNTech SE $5,319.85 6
Aadi Bioscience, Inc. $4,026.50 4
BeiGene USA, Inc. $3,900.00 2
Regeneron Pharmaceuticals, Inc. $3,708.36 3
Novocure Inc. $3,200.00 1
EISAI INC. $2,445.00 1
Eli Lilly and Company $1,600.00 1
E.R. Squibb & Sons, L.L.C. $560.00 1
Virtual Incision Corporation $500.00 1
Astellas Pharma US Inc $22.21 1
Acerta Pharma LLC $15.62 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $54,318.23 66
PY2019 $95,446.53 88
PY2020 $74,407.14 45
PY2021 $90,219.00 40
PY2022 $104,163.19 59
PY2023 $134,290.30 58
PY2024 $134,774.10 73

Payment records · PY2024 (73)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Aadi Bioscience, Inc. $89.00 03/16/2024 Food and Beverage Undisputed 01/23/2026 1119596859 CMS
Aadi Bioscience, Inc. $2,975.00 07/26/2024 Consulting Fee Undisputed 01/23/2026 1119596861 CMS
Aadi Bioscience, Inc. $112.50 07/26/2024 Food and Beverage Undisputed 01/23/2026 1119596863 CMS
Aadi Bioscience, Inc. $850.00 10/16/2024 Consulting Fee Undisputed 01/23/2026 1119596865 CMS
ABBVIE INC. $8,634.80 07/16/2024 Travel and Lodging Undisputed 01/23/2026 1105060578 CMS
ABBVIE INC. $2,450.00 07/19/2024 Consulting Fee Undisputed 01/23/2026 1105060580 CMS
ABBVIE INC. $4,550.00 09/18/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105060582 CMS
ABBVIE INC. $30.00 10/17/2024 Food and Beverage Undisputed 01/23/2026 1105060584 CMS
Astellas Pharma US Inc $22.21 02/13/2024 Food and Beverage Undisputed 01/23/2026 1139271258 CMS
AstraZeneca Pharmaceuticals LP $15.62 05/05/2024 Food and Beverage Undisputed 01/23/2026 1110547216 CMS
BeiGene USA, Inc. $1,950.00 11/20/2024 Consulting Fee Undisputed 01/23/2026 1120866986 CMS
BeiGene USA, Inc. $1,950.00 11/20/2024 Consulting Fee Undisputed 01/23/2026 1120866988 CMS
BioNTech SE $17.27 09/13/2024 Food and Beverage Undisputed 01/23/2026 1150660444 CMS
BioNTech SE $74.25 09/13/2024 Food and Beverage Undisputed 01/23/2026 1150660448 CMS
BioNTech SE $1,950.00 10/09/2024 Consulting Fee Undisputed 01/23/2026 1150660558 CMS
BioNTech SE $7.86 10/19/2024 Food and Beverage Undisputed 01/23/2026 1150660446 CMS
BioNTech SE $20.47 10/19/2024 Food and Beverage Undisputed 01/23/2026 1150660450 CMS
BioNTech SE $3,250.00 12/03/2024 Consulting Fee Undisputed 01/23/2026 1150660556 CMS
Corcept Therapeutics $1,300.00 07/23/2024 Consulting Fee Undisputed 01/23/2026 1117756721 CMS
Corcept Therapeutics $1,950.00 09/12/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1117756813 CMS
Corcept Therapeutics $67.83 09/12/2024 Food and Beverage Undisputed 01/23/2026 1117756817 CMS
Corcept Therapeutics $4,580.82 09/12/2024 Travel and Lodging Undisputed 01/23/2026 1117756819 CMS
Daiichi Sankyo Inc. $1,370.00 02/21/2024 Consulting Fee Undisputed 01/23/2026 1089459074 CMS
Daiichi Sankyo Inc. $1,712.50 02/21/2024 Consulting Fee Undisputed 01/23/2026 1089459080 CMS
Daiichi Sankyo Inc. $1,860.00 03/21/2024 Consulting Fee Undisputed 01/23/2026 1089459088 CMS
Daiichi Sankyo Inc. $3,100.00 04/03/2024 Consulting Fee Undisputed 01/23/2026 1089459066 CMS
Daiichi Sankyo Inc. $3,100.00 05/22/2024 Consulting Fee Undisputed 01/23/2026 1089459086 CMS
Daiichi Sankyo Inc. $1,240.00 05/29/2024 Consulting Fee Undisputed 01/23/2026 1089459062 CMS
Daiichi Sankyo Inc. $620.00 05/29/2024 Consulting Fee Undisputed 01/23/2026 1089459068 CMS
Daiichi Sankyo Inc. $28.57 05/31/2024 Food and Beverage Undisputed 01/23/2026 1089459142 CMS
Daiichi Sankyo Inc. $55.57 05/31/2024 Food and Beverage Undisputed 01/23/2026 1089459144 CMS
Daiichi Sankyo Inc. $1,860.00 07/03/2024 Consulting Fee Undisputed 01/23/2026 1089459064 CMS
Daiichi Sankyo Inc. $1,550.00 07/03/2024 Consulting Fee Undisputed 01/23/2026 1089459070 CMS
Daiichi Sankyo Inc. $2,740.00 07/03/2024 Consulting Fee Undisputed 01/23/2026 1089459084 CMS
Daiichi Sankyo Inc. $775.00 10/02/2024 Consulting Fee Undisputed 01/23/2026 1089459072 CMS
Daiichi Sankyo Inc. $620.00 11/27/2024 Consulting Fee Undisputed 01/23/2026 1089459078 CMS
E.R. Squibb & Sons, L.L.C. $560.00 03/22/2024 Consulting Fee Undisputed 01/23/2026 1101246032 CMS
Eisai Inc. $2,445.00 06/20/2024 Consulting Fee Undisputed 01/23/2026 1110757612 CMS
Eli Lilly and Company $1,600.00 03/14/2024 Consulting Fee Undisputed 01/23/2026 1135076723 CMS
Genmab U.S., Inc. $13,082.77 12/12/2024 Travel and Lodging Undisputed 01/23/2026 1126828486 CMS
Genmab U.S., Inc. $622.21 12/13/2024 Travel and Lodging Undisputed 01/23/2026 1126828488 CMS
Genmab U.S., Inc. $5,600.00 12/14/2024 Consulting Fee Undisputed 01/23/2026 1126828484 CMS
Genmab U.S., Inc. $56.79 12/14/2024 Food and Beverage Undisputed 01/23/2026 1126828490 CMS
GlaxoSmithKline, LLC. $71.66 03/15/2024 Food and Beverage Undisputed 01/23/2026 1116716559 CMS
GlaxoSmithKline, LLC. $20.73 03/15/2024 Food and Beverage Undisputed 01/23/2026 1116728898 CMS
GlaxoSmithKline, LLC. $15.93 09/14/2024 Food and Beverage Undisputed 01/23/2026 1115726095 CMS
GlaxoSmithKline, LLC. $58.42 09/14/2024 Food and Beverage Undisputed 01/23/2026 1116094296 CMS
GlaxoSmithKline, LLC. $14,400.00 12/10/2024 Consulting Fee Undisputed 01/23/2026 1116472025 CMS
Merck Sharp & Dohme LLC $247.47 11/07/2024 Travel and Lodging Undisputed 01/23/2026 1141871515 CMS
Merck Sharp & Dohme LLC $95.00 11/08/2024 Food and Beverage Undisputed 01/23/2026 1141702639 CMS
Merck Sharp & Dohme LLC $55.00 11/08/2024 Food and Beverage Undisputed 01/23/2026 1141702641 CMS
Merck Sharp & Dohme LLC $247.47 11/08/2024 Travel and Lodging Undisputed 01/23/2026 1141702643 CMS
Merck Sharp & Dohme LLC $772.57 11/08/2024 Travel and Lodging Undisputed 01/23/2026 1141702645 CMS
Merck Sharp & Dohme LLC $208.75 11/08/2024 Travel and Lodging Undisputed 01/23/2026 1141702647 CMS
Merck Sharp & Dohme LLC $45.98 11/08/2024 Food and Beverage Undisputed 01/23/2026 1141702649 CMS
Merck Sharp & Dohme LLC $48.00 11/08/2024 Food and Beverage Undisputed 01/23/2026 1141702651 CMS
Merck Sharp & Dohme LLC $288.33 11/08/2024 Travel and Lodging Undisputed 01/23/2026 1141871497 CMS
Merck Sharp & Dohme LLC $45.98 11/09/2024 Food and Beverage Undisputed 01/23/2026 1141871499 CMS
Merck Sharp & Dohme LLC $6,710.00 11/18/2024 Consulting Fee Undisputed 01/23/2026 1141551939 CMS
Merck Sharp & Dohme LLC $150.00 11/18/2024 Travel and Lodging Undisputed 01/23/2026 1141551941 CMS
Merck Sharp & Dohme LLC $5,490.00 11/18/2024 Consulting Fee Undisputed 01/23/2026 1141551943 CMS
Merck Sharp & Dohme LLC $150.00 11/18/2024 Travel and Lodging Undisputed 01/23/2026 1141551945 CMS
Novocure Inc. $3,200.00 05/30/2024 Honoraria Undisputed 01/23/2026 1141407982 CMS
Regeneron Pharmaceuticals, Inc. $99.36 06/02/2024 Food and Beverage Undisputed 01/23/2026 1114402833 CMS
Regeneron Pharmaceuticals, Inc. $802.00 09/06/2024 Consulting Fee Undisputed 01/23/2026 1114402835 CMS
Regeneron Pharmaceuticals, Inc. $2,807.00 09/06/2024 Consulting Fee Undisputed 01/23/2026 1114402837 CMS
Takeda Pharmaceuticals U.S.A., Inc. $9,271.00 08/17/2024 Travel and Lodging Undisputed 01/23/2026 1144963432 CMS
Takeda Pharmaceuticals U.S.A., Inc. $10.11 08/17/2024 Food and Beverage Undisputed 01/23/2026 1144963434 CMS
Takeda Pharmaceuticals U.S.A., Inc. $91.83 08/17/2024 Food and Beverage Undisputed 01/23/2026 1144963436 CMS
Takeda Pharmaceuticals U.S.A., Inc. $648.47 08/18/2024 Travel and Lodging Undisputed 01/23/2026 1144963438 CMS
Takeda Pharmaceuticals U.S.A., Inc. $417.00 08/18/2024 Travel and Lodging Undisputed 01/23/2026 1144963440 CMS
Takeda Pharmaceuticals U.S.A., Inc. $6,360.00 09/30/2024 Consulting Fee Undisputed 01/23/2026 1144963442 CMS
Virtual Incision Corporation $500.00 10/15/2024 Consulting Fee Undisputed 01/23/2026 1152112965 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.